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Abstract
Background:  The metabolic syndrome is characterized by the clustering of several traits,
including obesity, hypertension, decreased levels of HDL cholesterol, and increased levels of
glucose and triglycerides. Because these traits cluster, there are likely common genetic factors
involved.
Results: We used a multivariate structural equation model (SEM) approach to scan the genome
for loci involved in the metabolic syndrome. We found moderate evidence for linkage on
chromosomes 2, 3, 11, 13, and 15, and these loci appear to have different relative effects on the
component traits of the metabolic syndrome.
Conclusion: Our results suggest that the metabolic syndrome components, diabetes, obesity, and
hypertension, are under the pleiotropic control of several loci.
Background
Metabolic syndrome (MSX) is characterized by the aggre-
gation of several risk factors, including obesity, impaired
glucose tolerance, elevated triglyceride levels and blood
pressure, and low HDL cholesterol [1]. These factors pro-
mote the development of insulin resistance, diabetes,
renal insufficiency, and cardiovascular disease. The preva-
lence of MSX in the United States has been estimated to be
18–24% [2,3]. Studies of the components of MSX demon-
strate a substantial contribution of both genetic and envi-
ronmental factors to disease risk [4].
Methods that account for shared environmental influence
on the components of MSX are necessary if the genetic var-
iance is not to be overestimated. Structural equation mod-
els (SEM) comprise a valuable method for partitioning the
variance into its genetic and shared environmental com-
ponents. A previous SEM analysis has suggested that the
components of MSX are pleiotropically influenced by
common genetic factors [5]. Thus, a multivariate analysis
of the traits involved may increase power to detect quan-
titative trait loci (QTL) related to MSX. Although data
reductive techniques such as principal component analy-
sis have been performed (e.g. [6,7]), few comprehensive
multivariate analyses have been done. In this paper, we
analyzed the data from the Framingham offspring study
using SEM, which enabled us to model traits related to
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MSX simultaneously with genetic data and perform a
genome scan.
Methods
Data
We analyzed data from the offspring cohort of the Fram-
ingham Heart Study, provided for Problem 1 of Genetic
Analysis Workshop 13. The analysis was performed on all
individuals with complete genotypic and phenotypic data
for the fifth time point; this sample consisted of 1097
individuals from 381 pedigrees for a total of 1220 sib-
pairs. The proportion of males and females was roughly
equal, and the mean age was 51.33 (± 10.01) years. We
modeled MSX using the measurements taken at the fifth
time point for systolic blood pressure (SBP), fasting
plasma glucose (GLUC), triglycerides (TG), HDL choles-
terol (HDL), and body mass index (BMI), which was cal-
culated as weight(kg)/(height(m))2. Data from the final
time point were used because we hypothesized that the
study subjects would best demonstrate any progression to
MSX by this time. Both GLUC and TG were log-trans-
formed to reduce skewness. Because the distribution of
GLUC was leptokurtotic after log transformation, we fur-
ther transformed this variable using a generalized modu-
lus power transformation [8]. The shape and scale
parameters were estimated using ASSOC [9]. These five
phenotypes were covariate-adjusted for age, sex, number
of cigarettes smoked per day, number of drinks of alcohol
per day, and two-way interaction terms significant at the
α = 0.10 level using a stepwise regression model; there
were no significant three-way interactions. Standardized
residuals were obtained from the regression model and
used in the subsequent analyses. Both individual and sib-
ling correlations were estimated using FCOR [9].
Structural equation model (SEM)
Five adjusted phenotypes were used in multivariate link-
age analyses that simultaneously incorporate the pheno-
typic and genetic marker information into a single SEM, as
proposed by Eaves and colleagues [10] and implemented
in the Mx package [11]. This approach utilizes the full
cross-trait covariance structure between siblings to better
separate genetic from within-family environmental
effects, which offered several advantages. First, the incor-
poration of multiple traits in a linkage analysis offers a
considerable increase in power, particularly when there is
shared environmental variation, even for traits with low
heritability [12]. It has been shown that continuous traits
have considerably more power for linkage analysis than
do binary traits [13]. Finally, this approach is particularly
applicable for the measurement of putative "endopheno-
types" and is capable of detecting multiple QTL with plei-
otropic effects [10].
The methodology is fully described in Eaves et al. [10].
Briefly, using their notation, the sibpair covariance matrix
is expected to be
where AA' and EE' are the covariance matrices due to addi-
tive genetic and within-family environmental effects,
respectively. The information contained about the QTL
contained in cross-trait covariances is used to estimate the
effects of a putative QTL. The resulting sib-pair covariance
matrix is
where k is the number of alleles shared identical by
descent (IBD) at the location s, fk is the expected propor-
tion of pairs in a random sample sharing k alleles IBD (1/
4, 1/2, 1/4), and AA' and EE' are residual additive genetic
and environmental effects, after accounting for QQ', the
contribution of the QTL effects at the genetic location in
question. The SEM including QTL effects is illustrated in
Figure 1. The proportion of alleles shared IBD at a genetic
locus determines the correlation between the siblings'
QTL effects. Thus, two models are evaluated: one with the
SEM alone, and another weighted by the IBD probabilities
for each sibpair for each genetic locus. Twice the differ-
ence between the log likelihood values for these two mod-
els gives a likelihood ratio statistic. The contributions of
the putative genetic loci to each phenotype are repre-
sented as orthogonal factors. If these values (provided in
Table 2) are squared, they represent the heritability of the
phenotype due to that QTL. We estimated multi-point
IBD probabilities using GENIBD [9] at 2cM intervals
along the genome, using the parental genotypes from the
original Framingham cohort. The linkage analysis was
performed using Mx (script available on the Mx home
page [14]).
Results
The individual- and sibling-specific correlations of the
adjusted variables are provided in Table 1. This correla-
tion matrix demonstrates that MSX phenotypes cluster
within individuals, and that the five phenotypes are corre-
lated between siblings. For each linked region from the
SEM-based genome scan, the most significant p-values
and associated QTL contributions for each phenotype are
provided (Table 2). Though no regions attained statistical
significance by conventional criteria [15], loci on chromo-
somes 2, 3, 11, 13, and 15 demonstrated tentative evi-
dence for linkage at markers D2S1353, AFM306yg5,
D11S2008, D13S793, D15S165, and D15S642, respec-
tively. Weaker but potential evidence for linkage was seen
on chromosomes 4 and 17 at markers D4S1647 and
AFM290vc9, respectively. The QTL contributions to each
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phenotype were estimated. Negative QTL contributions
imply that the putative QTL acts to lower the trait value
(for example, low HDL increases risk for MSX). For most
linked regions, GLUC had the largest contribution,
though BMI and SBP were substantially influenced by the
QTL as well. Interestingly, TG occasionally had negative
QTL contributions and HDL had positive contributions
for some loci. Though counterintuitive at first glance, this
is most likely an artifact of imprecise estimation. In gen-
eral, TG and HDL did not yield as strong evidence for link-
age as did GLUC, BMI, and SBP.
Discussion
Previous multivariate analyses of MSX phenotypes have
found that insulin and adiposity are highly correlated,
and suggested that common genetic factors influence
them [5,6]. Utilizing genome-scan data from the Framing-
ham offspring data in conjunction with SEM, we have
identified possible loci on several chromosomes that have
pleiotropic effects on the component traits of MSX. SEM
indicated that the greatest impact of the QTLs was on
GLUC, although BMI and SBP were also influenced by
these loci, supporting the hypothesis that obesity, glucose
intolerance, and hypertension are key factors in MSX [5-
7]. Previous factor analyses for MSX are inconsistent with
these observations, as glucose and obesity variables fre-
quently loaded together, but there was seldom overlap
with blood pressure factors [16].
We observed moderate linkage on chromosomes 2, 3, 4,
11, 13, and 15, although the relative effect of these puta-
tive QTL on each MSX phenotype appears to differ.
Path diagram of structural equation model Figure 1
Path diagram of structural equation model. Gc and Ec are the genetic and environmental influences common to all the 
components of MSX, respectively, while Gs and Es are the genetic and environmental influences specific to each component.
Table 1: Individual- and sibling-specific correlations.
GLUC TG BMI HDL SBP
GLUC 0.2306 0.2118 0.3187 -0.1784 0.2491
TG 0.0670 0.2247 0.2917 -0.5326 0.3316
BMI 0.1130 0.0973 0.2921 -0.2883 0.2206
HDL -0.0276 -0.1911 -0.0624 0.2622 -0.1024
SBP 0.1143 0.0786 0.1027 -0.0620 0.1825
Unbolded values are individual-specific correlations; bolded values are sibling-specific correlations.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S99
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Because the literature related to linkage signals for MSX
components is vast, we have summarized reports within a
30cM window of our linkage signals [17]. Though we con-
ducted a truly multivariate analysis of MSX, our results can
be considered confirmations of these previous reports.
Body size [7], diabetes mellitus [18], and insulin resist-
ance [19] have been linked to chromosome 11; this region
also contains several candidate genes, including insulin
(OMIM 17673), SHIP2 (OMIM 600829), and the uncou-
pling protein 2 (OMIM 601693) [20]. An adiposity-insu-
lin factor attained suggestive linkage to chromosome 2
[6], and a separate study found linkage to BMI 20 cM away
[21]. Insulin resistance [19], BMI [19], and high blood
pressure [22] have been linked to chromosome 3. Leptin
levels have been linked to the 20-cM location on chromo-
some 15 [21]. Finally, IRS-2, a diabetes candidate gene,
has been mapped to chromosome 13 (102 cM) [23].
Given the multifactorial nature of MSX, the method of
linkage analysis most suitable is one that incorporates all
available trait information. Here we use SEM with multi-
variate data to increase power, account for shared sibling
environment within a sib-pair linkage analysis, and depict
the combined effects of the components of MSX simulta-
neously. This approach is uniquely capable of estimating
the contribution of each phenotype to the QTL, which can
illustrate facets of MSX biology. Another advantage of our
approach is the direct use of quantitative traits. Currently,
there are two different clinical definitions of MSX [2],
which require the presence of at least two (or three) of five
characteristics. By analyzing the full quantitative scale for
each MSX component, not only do we gain power statisti-
cally, but we also avoid classifying individuals together
who have moderate to extreme trait values. As observed in
Table 1, these traits are not highly correlated with each
other, but our genome scan results suggest that they may
be influenced by common genetic factors.
There are, however, limitations to these analyses.
Although there were data available on blood pressure
medication, there were no data on diabetes medication.
Since both were not available, we did not adjust our quan-
titative variables for these covariates. Because of missing
genotype and/or phenotype data, approximately 700 sib-
pairs were excluded from this analysis. Though our sam-
ple size was still substantial, it is unknown how these
sibpairs might have increased power. There is an upward
bias in the estimation of the QTL contributions. The sum
of the squared QTL contributions to GLUC for all distinct
linked regions is greater than 1, which is not possible if
these values are interpreted to be QTL-specific heritabili-
ties. Also, when partitioning genetic and shared-environ-
mental components of variance, gene×environment
interaction was unaccounted for, and allowing for such
interaction would only exacerbate the discrepancy.
Finally, in the SEM, all sibpairs were treated as though
they were independent. It is unclear how to handle larger
sibships within the SEM; however, the average sibship size
is less than three, so this should not have a great impact
on the analysis.
Another point worth revisiting is our approach to non-
normal data. The SEM assumes multivariate normality
and, with increasing sample size, departure from this
assumption will affect the likelihood ratio test adversely.
In our analysis, the GLUC variable was transformed using
a generalized modulus power transformation [8] to
remove skewness and kurtosis. Though the departure of
this variable from normality may be regarded as biologi-
cally based [24], a leptokurtotic distribution leads to an
inflated type I error rate [24], and the scale of measure-
ment may drastically affect results of linkage analysis [25].
In fact, when this analysis was performed without trans-
formation, most of the linkage results were more signifi-
cant, and the QTL contributions were incorrectly inflated
Table 2: Linked regions for MS identified using SEM.A
QTL contribution
Region Location (cM) p-Value GLUC TG BMI HDL SBP
2q24.2 165 0.003 0.4633 0.1344 0.3305 -0.1086 0.3044
3p21.31-3p13 71–112 0.003 0.4537 0.2567 0.4101 -0.0987 0.2894
4q24.2 88 0.024 0.2258 -0.0360 0.3348 -0.0823 0.4879
11p15.5-
11q23.3
9–113 0.003 0.3352 0.2877 0.3639 -0.0588 0.3417
12q14.3-12q15 78 0.029 0.2242 0.0290 0.3839 0.0366 0.4476
13q32 76 0.009 0.3393 0.1286 0.2361 0.0127 0.3627
15q11.2-
15q31.1
5–20 0.005 0.3221 -0.0547 0.0433 -0.2067 0.2927
15q26.3 122 0.011 0.4494 0.1068 0.2088 -0.0454 0.3349
17p12 31–32 0.030 0.2102 0.1363 0.2268 -0.0275 0.4786
AMarker names are provided within the text.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S99
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(data not shown). After transformation, the relative effects
on the other MSX traits increased, indicating that the
variance was partitioned more evenly when univariate
normality of the five traits was attained.
Conclusions
A number of loci appear to be linked to MSX, most nota-
bly regions on chromosomes 2, 3, 11, 13, and 15. Diabe-
tes, obesity, and hypertension were most influenced by
these loci. These regions appear to influence the compo-
nents of MSX in different ways, and they warrant further
analysis, both in reference to the metabolic syndrome
itself and to other disorders associated with insulin-resist-
ance.
Acknowledgments
This study was supported in part by U.S. Public Health Service Grants 
HL07567 from the National Heart, Lung, and Blood Institute, HG01577 
from the National Human Genome Research Institute, RR03655 from the 
National Center for Research Resources, GM28356 from the National 
Institute of General Medicine Sciences, DK54644 and DK57292 from the 
National Institute of Diabetes and Digestive and Kidney Diseases, and NIH 
grants RR08123 and MH01458. Some of the results of this paper were 
obtained by using the program package S.A.G.E., which is supported by a 
U.S. Public Health Resource Grant (1 P41 RR 03655). CMS sincerely thanks 
Dr. Michael Neale for all his help using the Mx software and Courtney 
Gray-McGuire for helpful discussion.
References
1. Expert Panel on the Detection Evaluation and Treatment of High
Blood Cholesterol in Adults: Executive Summary of the Third
Report of the National Cholesterol Education Treatment
Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III). JAMA 2001, 285:2486-2497.
2. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: Prevalence
of metabolic syndrome and coronary heart disease using
NCEP and WHO criteria [abstract]. Diabetes 2002, 51(suppl
2):A218.
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syn-
drome among US adults: findings from the third national
health and nutrition examination survey.  JAMA 2002,
287:356-359.
4. Groop L: Genetics of the metabolic syndrome. Br J Nutr 2000,
83(suppl):S39-S48.
5. Hong Y, Pedersen NL, Brismar K, de Faire U: Genetic and environ-
mental architecture of the features of the insulin-resistance
syndrome. Am J Hum Genet 1997, 60:143-152.
6. Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ, O'Con-
nell P, Stern MP, Duggirala R: Factors of insulin-resistance syn-
drome-related phenotypes are linked to genetic locations on
chromosomes 6 and 7 in nondiabetic Mexican-Americans.
Diabetes 2002, 51:841-847.
7. Imperatore G, Knowler WC, Kobes S, Bennett PH, Hanson RL:
Genome-wide linkage analysis of factors characterizing the
metabolic syndrome among Pima Indians [abstract]. Diabetes
1999, 48(suppl):A182.
8. George VT, Elston RC: Generalized modulus power
transformations. Commun Statist Theory Meth 1988, 17:2933-2952.
9. SA.G.E., version 4.2.: Statistical Analysis for Genetic Epidemiol-
ogy. A computer package available from Statistical Solutions, Cork, Ireland
2002.
10. Eaves LJ, Neale MC, Maes H: Multivariate multipoint linkage
analysis of quantitative trait loci. Behav Genet 1996, 26:519-525.
11. Neale MC: Mx: Statistical Modeling, 5th edition. Medical College
of Virginia, Richmond, VA 1999.
12. Schmitz S, Cherny SS, Fulker DW: Increase in power through
multivariate analyses. Behav Genet 1998, 28:357-363.
13. Duggirala R, Williams JT, Williams-Blangero S, Blangero J: A variance
components approach to dichotomous trait linkage analysis
using a threshold model. Genet Epidemiol 1997, 14:987-992.
14. Mx software homepage  [http://views.vcu.edu/mx/]
15. Lander E, Kruglyak L: Genetic dissection of complex traits:
guidelines for interpreting and reporting linkage results. Nat
Genet 1995, 11:241-247.
16. Meigs JB: Invited commentary: Insulin resistance syndrome?
Syndrome X? Multiple metabolic syndrome? A syndrome at
all? Factor analysis reveals patterns in the fabric of corre-
lated metabolic risk factors. Am J Epidemiol 2000, 152:908-911.
17. Cordell HJ: Sample size requirements to control for stochas-
tic variation in magnitude and location of allele-sharing link-
age statistics in affected sibling pairs.  Ann Hum Genet 2001,
65:491-502.
18. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL,
Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K, Chines
P, Balow J Jr, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala
ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A,
Musick T, Pfahl C, Porter R, Rayman JB: The Finland-United
States investigation of non-insulin-dependent diabetes melli-
tus genetics (FUSION) study. I. An autosomal genome scan
for genes that predispose to type 2 diabetes. Am J Hum Genet
2000, 67:1174-1185.
19. Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnu-
son VL, Mohlke KL, Silander K, Ally DS, Chines P, Blaschak-Harvan J,
Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange
EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Balow J
Jr, Birznieks G, Chang J, Eldridge W: The Finland-United States
investigation of non-insulin-dependent diabetes mellitus
genetics (FUSION) study. II. An autosomal genome scan for
diabetes-related quantitative trait loci. Am J Hum Genet 2000,
67:1186-1200.
20. Online Mendelian Inheritance in Man  [http://
www3.ncbi.nlm.nih.gov/omim/]
21. Cheng LS-C, Davis RC, Raffel LJ, Xiang AH, Wang N, Quiñones M,
Wen P-Z, Toscano E, Diaz J, Pressman S, Henderson PC, Azen SP,
Hsueh WA, Buchanan TA, Rotter JI: Coincident linkage of fasting
plasma insulin and blood pressure to chromosome 7q in
hypertensive Hispanic families. Circulation 2001, 104:1255-60.
22. Francke S, Manraj M, Lacquemant C, Leoceur C, Leprêtre F, Passa P,
Hebe A, Corset L, Yan SLK, Lahmidi S, Jankee S, Gunness TK, Ram-
juttun US, Balgobin V, Dina C, Froguel P: A genome-wide scan for
coronary heart disease suggests in Indo-Mauritians a suscep-
tibility locus on chromosome 16p13 and replicates linkage
with the metabolic syndrome on 3q27. Hum Mol Genet 2001,
10:2751-65.
23. Kalidas K, Wasson J, Glaser B, Meyer JM, Duprat LJ, White MF, Per-
mutt MA: Mapping of the human insulin receptor substrate-2
gene, identification of a linked polymorphic marker and link-
age analysis in families with Type II diabetes: no evidence for
a major susceptibility role. Diabetologia 1998, 41:1389-91.
24. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J:
Testing the robustness of the likelihood-ratio test in a vari-
ance-component quantitative-trait loci-mapping procedure.
Am J Hum Genet 1999, 65:531-544.
25. Wilson AF, Elston RC, Tran LD, Siervogel RM: Use of the robust
sib-pair method to screen for single-locus, multiple-locus,
and pleiotropic effects: application to traits related to
hypertension. Am J Hum Genet 1991, 48:862-872.